# Prevention of Iron Deficiency Anemia Post-delivery

> **NCT05590260** · PHASE3 · UNKNOWN · sponsor: **NICHD Global Network for Women's and Children's Health** · enrollment: 4800 (estimated)

## Conditions studied

- Postpartum Anemia

## Interventions

- **DRUG:** IV iron infusion
- **DRUG:** Oral iron tablets

## Key facts

- **NCT ID:** NCT05590260
- **Lead sponsor:** NICHD Global Network for Women's and Children's Health
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-30
- **Primary completion:** 2025-10-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 4800 (ESTIMATED)
- **Last updated:** 2023-12-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05590260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05590260, "Prevention of Iron Deficiency Anemia Post-delivery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05590260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*